Themis Medicare Limited (NSE:THEMISMED)
168.20
+17.10 (11.32%)
May 19, 2025, 3:29 PM IST
Themis Medicare Revenue
Themis Medicare had revenue of 938.06M INR in the quarter ending December 31, 2024, with 13.69% growth. This brings the company's revenue in the last twelve months to 4.32B, up 18.56% year-over-year. In the fiscal year ending March 31, 2024, Themis Medicare had annual revenue of 3.82B with 7.74% growth.
Revenue (ttm)
4.32B
Revenue Growth
+18.56%
P/S Ratio
3.19
Revenue / Employee
2.86M
Employees
1,509
Market Cap
13.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3.82B | 274.38M | 7.74% |
Mar 31, 2023 | 3.54B | -402.91M | -10.21% |
Mar 31, 2022 | 3.95B | 1.64B | 71.07% |
Mar 31, 2021 | 2.31B | 290.82M | 14.43% |
Mar 31, 2020 | 2.02B | 178.34M | 9.71% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 271.45B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |